CompuGroup Medical SE KgaA (XTER:COP) COGS-to-Revenue : 0.16 (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA COGS-to-Revenue?

CompuGroup Medical SE KgaA's Cost of Goods Sold for the three months ended in Mar. 2025 was €44 Mil. Its Revenue for the three months ended in Mar. 2025 was €286 Mil.

CompuGroup Medical SE KgaA's COGS to Revenue for the three months ended in Mar. 2025 was 0.16.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CompuGroup Medical SE KgaA's Gross Margin % for the three months ended in Mar. 2025 was 84.49%.

CompuGroup Medical SE KgaA COGS-to-Revenue Historical Data

The historical data trend for CompuGroup Medical SE KgaA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA COGS-to-Revenue Chart

CompuGroup Medical SE KgaA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.15

0.16

CompuGroup Medical SE KgaA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.16	0.15	0.16	0.18	0.16

CompuGroup Medical SE KgaA COGS-to-Revenue Calculation

CompuGroup Medical SE KgaA's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	188.844	/	1153.987
	=	0.16

CompuGroup Medical SE KgaA's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	44.381	/	286.156
	=	0.16

CompuGroup Medical SE KgaA (XTER:COP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CompuGroup Medical SE KgaA's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	44.381 / 286.156
	=	84.49 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

CompuGroup Medical SE KgaA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CompuGroup Medical SE KgaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CMPUY:USA 0MSD:UK COP:Austria

Address

Maria Trost 21, Koblenz, DEU, 56070

Website

https://www.cgm.com

CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.

Executives

Daniela Hommel	CFO, Managing director of the general partner of the issuer
Michael Rauch	Managing director of the general partner of the issuer
Emanuele Mugnani	Managing director of the general partner of the issuer
Frank Gotthardt	Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt	Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl	Managing director of the general partner of the issuer
Dr. Eckart Pech	Managing director of the general partner of the issuer
Dr. Dirk Wössner	CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen	Managing director of the general partner of the issuer